Category: PMCPA Case of the Week

Cases selected for the AskAnzal weekly PMCPA insight newsletter

8 Mar 2026

AstraZeneca breached ABPI Code over Forxiga β€œstart on 10mg” dosing claims hidden behind footnote (AUTH/3618/3/22)

Forxiga website and rep messaging implied all patients can start 10mg with no uptitration. Key 5mg start for…

8 Mar 2026

AUTH/3744/2/23: Boehringer Ingelheimβ€”Broken prescribing information link on promotional website (Pradaxa/Praxbind)

A third-party promotional webpage had a non-functioning single-click PI link for Pradaxa/Praxbind for ~3 weeks. An earlier email…

8 Mar 2026

AstraZeneca: promotional meeting misclassified and LinkedIn engagement led to pre-authorisation promotion and public advertising findings (AUTH/3729/1/23)

Six amalgamated complaints. Breaches found for a UK β€œthink tank” meeting (uncertified promotional content; β€˜cure’ implication) and LinkedIn…

8 Mar 2026

AUTH/3920/6/24: Complainant v AstraZeneca β€” LinkedIn β€˜Experience’ section references to Enhertu (no breach)

Complaint alleged a senior employee’s LinkedIn β€˜Experience’ section promoted Enhertu to the public and off-label, using terms like…

8 Mar 2026

Pfizer Lipitor journal advertisement found misleading for exaggerating urgency to prescribe

A GP challenged a Lipitor journal ad using a fireman analogy. The Panel and Appeal Board found it…

8 Mar 2026

AUTH/2195/12/08: General Practitioner v Otsuka – Representative email to practice manager (conduct and disparaging comments)

A GP practice complained about an Otsuka representative’s unprofessional email (sent from work email) containing disparaging comments about…

8 Mar 2026

Anonymous v Lilly (AUTH/2220/3/09): Promotional content embedded in β€œindependent” diabetes course and excessive 1:1 meetings with consultant

Lilly was found in breach after a branded promotional presentation appeared to be part of a university diabetes…

8 Mar 2026

AUTH/2321/5/10: Media/Director v Roche β€” Tamiflu corporate sector approach and alleged inducements (No breach)

Financial Times alleged Roche pressured staff to sell Tamiflu to non-doctors and used cash payments/discounts. Panel found unclear…

8 Mar 2026

Cephalon: Lisbon congress hospitality and an internal β€œfeedback” note that normalised excessive entertainment (AUTH/2361/10/10)

Cephalon’s internal congress feedback note described β€œclubbing” and late-night bars with HCPs and urged β€œlets make sure they…

8 Mar 2026

Anonymous v Cephalon (AUTH/2409/6/11): Promotional material certified by non‑GMC registered β€œmedical” signatory

Cephalon discovered an interim medical adviser who certified ~45 promotional items was not GMC registered. PMCPA found a…

⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week β€” free.

Subscribe Free
🎓 AQP Training